• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响凝血的因素:慢性硬膜下积液中的纤维蛋白溶解

Factors affecting coagulation: fibrinolysis in chronic subdural fluid collections.

作者信息

Weir B, Gordon P

出版信息

J Neurosurg. 1983 Feb;58(2):242-5. doi: 10.3171/jns.1983.58.2.0242.

DOI:10.3171/jns.1983.58.2.0242
PMID:6848682
Abstract

Plasminogen, alpha2-antiplasmin, fibrinogen, fibrin degradation products (FDP's), and hemoglobin were measured in the supernatant fluid of 25 chronic subdural hematomas and five chronic subdural hygromas. The 30 patients underwent pre- and postoperative computerized tomography. The hematomas were characterized by low fibrinogen and high fibrin degradation product concentrations. The hemoglobin content varied directly with the alpha2-antiplasmin, and inversely with the plasminogen. Four patients underwent reoperation for recurrences. The initial fluid from these cases was characterized by relatively high plasminogen and low alpha2-antiplasmin. The hygromas had no hemoglobin, and low fibrinogen, high FDP's, low alpha2-antiplasmin, and variable plasminogen levels. It is possible that those cases having the greatest capacity to produce plasmin (high plasminogen and low alpha2-antiplasmin) can produce more FDP's which in turn causes more rebleeding and an increased risk of reaccumulation of chronic subdural hematomas.

摘要

对25例慢性硬膜下血肿和5例慢性硬膜下积液患者的上清液进行了纤溶酶原、α2-抗纤溶酶、纤维蛋白原、纤维蛋白降解产物(FDP)和血红蛋白的检测。这30例患者均接受了术前和术后的计算机断层扫描。血肿的特点是纤维蛋白原浓度低,纤维蛋白降解产物浓度高。血红蛋白含量与α2-抗纤溶酶呈正相关,与纤溶酶原呈负相关。4例患者因复发接受了再次手术。这些病例的初始液体的特点是纤溶酶原相对较高,α2-抗纤溶酶较低。积液中没有血红蛋白,纤维蛋白原含量低,FDP含量高,α2-抗纤溶酶含量低,纤溶酶原水平变化不定。那些产生纤溶酶能力最强(纤溶酶原高而α2-抗纤溶酶低)的病例可能会产生更多的FDP,进而导致更多的再出血以及慢性硬膜下血肿再积聚的风险增加。

相似文献

1
Factors affecting coagulation: fibrinolysis in chronic subdural fluid collections.影响凝血的因素:慢性硬膜下积液中的纤维蛋白溶解
J Neurosurg. 1983 Feb;58(2):242-5. doi: 10.3171/jns.1983.58.2.0242.
2
Role of local hyperfibrinolysis in the etiology of chronic subdural hematoma.局部纤溶亢进在慢性硬膜下血肿病因学中的作用。
J Neurosurg. 1976 Jul;45(1):26-31. doi: 10.3171/jns.1976.45.1.0026.
3
Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.患有急性胃肠道疾病马匹的血管内和腹膜内凝血与纤溶
J Am Vet Med Assoc. 1995 Aug 15;207(4):465-70.
4
Characterization of local hyperfibrinolysis in chronic subdural hematomas by SDS-PAGE and immunoblot.通过SDS-PAGE和免疫印迹法对慢性硬膜下血肿局部高纤溶状态的特征分析
J Neurosurg. 1994 Dec;81(6):910-3. doi: 10.3171/jns.1994.81.6.0910.
5
Coagulation and fibrinolysis in chronic subdural hematoma.慢性硬膜下血肿中的凝血与纤溶
Neurosurgery. 1989 Jul;25(1):25-9. doi: 10.1097/00006123-198907000-00005.
6
Effects of exploratory laparotomy on plasma and peritoneal coagulation/fibrinolysis in horses.剖腹探查术对马血浆及腹膜凝血/纤溶的影响。
Am J Vet Res. 1991 Jul;52(7):1121-7.
7
Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.急性脑梗死患者rt-PA治疗后溶栓后止血变化。与心源性栓塞病因及预后的相关性。
J Neurol Sci. 2015 Feb 15;349(1-2):77-83. doi: 10.1016/j.jns.2014.12.029. Epub 2014 Dec 29.
8
[Detection of fibrinolysis in chronic subdural hematoma].[慢性硬膜下血肿中纤维蛋白溶解的检测]
Neurochirurgia (Stuttg). 1986 May;29(3):78-82. doi: 10.1055/s-2008-1053707.
9
High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.高血浆纤维蛋白原水平与弥散性血管内凝血患者的不良临床结局相关。
Am J Hematol. 2003 Jan;72(1):1-7. doi: 10.1002/ajh.10249.
10
Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage.蛛网膜下腔出血后脑脊液中纤维蛋白/纤维蛋白原降解产物的来源。
J Neurosurg. 1985 Oct;63(4):573-7. doi: 10.3171/jns.1985.63.4.0573.

引用本文的文献

1
Is It Safe to Use Tranexamic Acid for Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis.使用氨甲环酸治疗慢性硬膜下血肿是否安全:一项系统评价和荟萃分析
Asian J Neurosurg. 2025 Jan 10;20(2):219-228. doi: 10.1055/s-0044-1801771. eCollection 2025 Jun.
2
Endoscopic Treatment of Chronic Subdural Hematoma Combined with Inner Subdural Hygroma.内镜治疗慢性硬膜下血肿合并硬膜下积液
J Korean Neurosurg Soc. 2023 Sep;66(5):552-561. doi: 10.3340/jkns.2023.0064. Epub 2023 Jun 19.
3
Risk Factors for Atorvastatin as a Monotherapy for Chronic Subdural Hematoma: A Retrospective Multifactor Analysis.
阿托伐他汀单药治疗慢性硬膜下血肿的危险因素:一项回顾性多因素分析
Front Aging Neurosci. 2021 Sep 1;13:726592. doi: 10.3389/fnagi.2021.726592. eCollection 2021.
4
Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy.慢性硬膜下血肿的病理生理学:炎症、血管生成及药物治疗的意义
J Neuroinflammation. 2017 May 30;14(1):108. doi: 10.1186/s12974-017-0881-y.
5
Chronic subdural hematoma: Surgical management and outcome in 986 cases: A classification and regression tree approach.慢性硬膜下血肿:986例患者的手术治疗及结果:一种分类与回归树分析方法
Surg Neurol Int. 2015 Jul 30;6:127. doi: 10.4103/2152-7806.161788. eCollection 2015.
6
Recent changes in risk factors of chronic subdural hematoma.慢性硬膜下血肿危险因素的近期变化。
J Korean Neurosurg Soc. 2012 Sep;52(3):234-9. doi: 10.3340/jkns.2012.52.3.234. Epub 2012 Sep 30.
7
Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study.慢性硬脑膜下血肿患者局部和全身促炎和抗炎细胞因子模式:一项前瞻性研究。
Inflamm Res. 2012 Aug;61(8):845-52. doi: 10.1007/s00011-012-0476-0. Epub 2012 Apr 19.
8
What are the causative factors for a slow, progressive enlargement of a chronic subdural hematoma?慢性硬膜下血肿缓慢、进行性增大的病因有哪些?
Yonsei Med J. 2007 Apr 30;48(2):210-7. doi: 10.3349/ymj.2007.48.2.210.
9
Outcome of contemporary surgery for chronic subdural haematoma: evidence based review.当代慢性硬膜下血肿手术的疗效:基于证据的综述。
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):937-43. doi: 10.1136/jnnp.74.7.937.
10
[Surgical outcome in chronic subdural hematoma].[慢性硬膜下血肿的手术结果]
Unfallchirurgie. 1996 Jun;22(3):110-6.